期刊文献+

雷帕霉素纳米粒滴眼液治疗兔高危角膜移植排斥反应 被引量:2

Influence of rapamycin nanometer vector eye drops on high-risk corneal allograft survival
下载PDF
导出
摘要 目的探讨雷帕霉素(RAPA)纳米粒滴眼液抑制高危角膜移植术后免疫排斥反应的疗效和机制。方法应用不同处理因素干预角膜移植术后免疫排斥反应,观察相关指标的变化。结果RAPA纳米粒滴眼液能明显延长角膜植片存活时间,并能使植片CD4+和CD8+T淋巴细胞表达时间延后。RAPA纳米粒滴眼液组植片中IL-2始终表达,而VEGF表达在14d开始被抑制。结论RAPA纳米粒滴眼液能延长高危角膜移植植片存活时间。 Objective Rapamycin(RAPA) is being concerned because of its stronger immunosuppressive effect and less toxicity to human tissue. Our study was to assess the immunosuppressive effect of RAPA nanometer vector eye drops on rejection of corneal allograft in rabbit model and its mechanism. Methods The corneal neovascular models were created in 94 New Zealand albino rabbits using cautery of 2 mol/L NaOH and divided into 5 groups. Group A( 17 eyes) was as control group with the 9 donors of New Zealand albino rabbits and 17 recipients from New Zealand albino rabbits, The corneal donor grafts from 34 gray rabbits were implanted to 68 recipients of New Zealand albino rabbits with corneal neovascularization. The recipients eyes from group B were not treated as controls. The nanometer vector eye drops without RAPA was used twice a day for 28 days in group B. 1% RAPA eye drops was topically administrated 3 times per day for 28 days in group C ,and 0.5% RAPA eye drops of nanometer vector was treated twice a day for 28 days in group E. Postoperative evaluation of grafts included slit-lamp biomicroscopy and immunohistology,and IL-2 and VEGF in corneal tissue were detected by RT-PCR,respectively. Results The mean survival time of grafts in group A was ( 100.0 ± 0.0) days, and that in group E (45.22 ± 5.52 days) was statistically significant prolonged compared with group B(ll. 11 ± 1.69 days) ,group C ( 11.78 ± 3.19 days) and group D( 17.78 ± 8.41 days) ( F = 562. 757 ,P = 0. 000). The grafts in group E appeared an delayed immune response, showing delayed infiltration of CD4 , CDs T lymphocytes compared with group B, group C and group D. The gene expression of IL-2 was not inhibited but VEGF was suppressed 14 days later in group E compared with group B, group C and group D. Conclusion The topical application of RAPA eye drops of nanometer vector can prolong the survival time of corneal grafts.
出处 《眼科研究》 CAS CSCD 北大核心 2007年第10期729-732,共4页 Chinese Ophthalmic Research
关键词 雷帕霉素 纳米粒 角膜移植 移植物排斥 rapamycin eye drops of nanometer vector corneal transplantation graft rejection
  • 相关文献

参考文献16

  • 1李民.雷帕霉素的作用机制和临床应用[J].国外医学(药学分册),2002,29(3):162-165. 被引量:9
  • 2周文天,俞益丰,邓青,黄旭.FK506胶原药膜抑制兔角膜移植的免疫排斥反应[J].眼科新进展,2004,24(4):254-256. 被引量:9
  • 3She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic,penetrating keratoplasty in the mouse [ J ]. Ophthalmic Surg, 1990,21:781 -785.
  • 4Hill JC, Maske R. An animal model for corneal graft rejection in high-risk keratoplasty [ J ]. Transplantation, 1988,46: 26 - 30.
  • 5Larkin DF,Calder VL,Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humor in rat corneal allograft rejection [ J ]. Clin Exp Immunol, 1997,107 : 381 - 391.
  • 6Reinhard T, Sundmacher R, Heering P. Systemic cyclosporin A in high risk keratoplasties[ J]. Graefe' s Arch Clin Exp Ophthalmol, 1996,234: 115 - 121.
  • 7Ryffel B,Car B,Weber E, et al. Nephrotoxieity of immunosuppressants in rats : comparison of macrolides with cyclosporine [ J ]. Exp Nephrol, 1994, 2 : 324 - 333.
  • 8Sturrock ND, Lang CC, Struthers AD, Cyclosporin-induced nephrotoxicity and hypertension[ J]. Br J Hosp Med,1992,52:480-483.
  • 9Mourad G, Vela C, Ribstein J, et al. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy [ J]. Transplantation, 1998,65 : 661 - 667.
  • 10Gronyo JM. Progress with eyelosporlne-sparing regimens [ J ]. Transplant Proc, 1999,31 : S11 - 16.

二级参考文献47

  • 1Kino T, Hatanaka H, Hashimoto M. FK506 a novel immunosuppressant isolated from a streptomyces fermentation isolation and biological characteristics [ J ]. J Antibiot 1987 ;40:1249-1255.
  • 2S1oper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts [ J]. Ophthalmology 2001; 108(10): 1838-1844.
  • 3Rao SK, Rajagopal R, Fogla R, Sitalakshmi G, Padmanabhan P. Llmbal allografting using FK-506[J]. Br J Ophthalmol 1999 ;83(12): 1409-1410.
  • 4Reis A, Reinhard T, Sundmacher R, Braunstein S, Godehardt E. Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal grafts[ J]. Transplant Proc 1998;30(8) :4344-4347.
  • 5Kobayashi C, Kanai A, Nakajima A, Okumur K. Suppreddion of corneal graft refection in rabbits by a new immunosuppressive agent FK506[J]. Transplant Proc 1989;21(1):3156.
  • 6Stepkowski SM, Chen H, Daloze P, et al. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat [J]. Transplantation, 1991, 51(1):22-26.
  • 7Granger DK, Cromwell JW, Chen SC, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy[J]. Transplantation, 1995, 59(2):183- 186.
  • 8Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin[J]. Annu Rev Immunol, 1996, 14:483 - 510.
  • 9Grinyo JM. Progress with cyclosporine-sparing regimens[J].Transplant Proc, 1999, 31(Suppl 8A): 11S- 16S.
  • 10Mourad G, Vela C, Ribstein J, et al. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy[J]. Transplantation, 1998, 65(5):661 -667.

共引文献38

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部